Vanqua Bio

Chicago, United States

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

$45.0M raised

Jul 2024

Venture - Series Unknown

Top Investors

Eli LillyOrbiMedOmega FundsPontifaxOUP (Osage University Partners)

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vanqua Bio raised?

Vanqua Bio has raised $45.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.

Who are Vanqua Bio's investors?

Vanqua Bio's investors include Eli Lilly, OrbiMed, Omega Funds, Pontifax, OUP (Osage University Partners).

Where is Vanqua Bio headquartered?

Vanqua Bio is headquartered in Chicago, United States.

What does Vanqua Bio do?

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

What stage is Vanqua Bio at?

Vanqua Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 5, 2024.

MLA

"Vanqua Bio — Funding & Investors." VCBacked, July 5, 2024, https://www.vcbacked.co/company/vanqua-bio. Accessed June 10, 2026.

APA

VCBacked. (2024). Vanqua Bio — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/vanqua-bio

Wikipedia (cite web)

{{cite web |title=Vanqua Bio — Funding & Investors |url=https://www.vcbacked.co/company/vanqua-bio |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 5, 2024.